We are live on ! Find out more
TCM

TimesSquare Capital Management Portfolio holdings

AUM $6.8B
1-Year Est. Return 45.85%
This Fund
S&P 500
This Quarter Est. Return
+3.2%
1 Year Est. Return
+45.85%
3 Year Est. Return
+131.54%
5 Year Est. Return
+149.79%
10 Year Est. Return
+765.84%
AUM
$7.19B
AUM Growth
+$18.8M
Cap. Flow
-$40.8M
Cap. Flow %
-0.57%
Top 10 Hldgs %
14.72%
Holding
203
New
14
Increased
81
Reduced
93
Closed
14

Top Buys

Rank Stock Value
1
APTV icon
Aptiv
APTV
+$67.6M
2
ROST icon
Ross Stores
ROST
+$52.8M
3
IDXX icon
Idexx Laboratories
IDXX
+$47.9M
4
AZPN
Aspen Technology Inc
AZPN
+$45.8M
5
LEGN icon
Legend Biotech
LEGN
+$39.9M

Top Sells

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$61M
2
TRU icon
TransUnion
TRU
+$56.2M
3
PCAR icon
PACCAR
PCAR
+$51.6M
4
SAIL
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
+$48.3M
5
CRL icon
Charles River Laboratories
CRL
+$43.4M

Sector Composition

Rank Sector Weight
1 Technology 27.74%
2 Industrials 20.24%
3 Healthcare 17.35%
4 Consumer Discretionary 13.22%
5 Financials 7.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SAIL
201
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
– –
-770,060
Closed -$48.3M
HZNP
202
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
– –
-764,800
Closed -$61M
ENV
203
DELISTED
ENVESTNET, INC.
ENV
– –
-405,450
Closed -$21.4M
5 6 7 8
9

Similar funds

CF
Cantor Fitzgerald New York $6.78B AUM 28.97% 1-Year Est. Return
JCAM
Jericho Capital Asset Management New York $6.76B AUM 88.1% 1-Year Est. Return
GAM
Groupama Asset Management Paris, France $6.85B AUM 43.37% 1-Year Est. Return
CIMLRA
CBRE Investment Management Listed Real Assets Radnor, Pennsylvania $6.75B AUM 8.88% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
SPS
Susquehanna Portfolio Strategies Bala Cynwyd, Pennsylvania $6.73B AUM 45.57% 1-Year Est. Return
BHM
Briar Hall Management Nashville, Tennessee $6.72B AUM 4.95% 1-Year Est. Return
MSE
MUFG Securities EMEA London, United Kingdom $6.7B AUM 32.3% 1-Year Est. Return

TimesSquare Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, TimesSquare Capital Management held 203 positions worth $7.19B, up 0.26% from $7.17B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

TimesSquare Capital Management's Q3 2022 filing shows 14 new, 81 increased, 93 reduced and 14 closed positions. Its largest new stake was Aptiv: 704,300 shares worth $55.1M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $61M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 28% a quarter earlier, followed by Industrials and Healthcare.

  • TimesSquare Capital Management's largest Q3 2022 buy was Aptiv: 704,300 shares worth $55.1M.
  • TimesSquare Capital Management added most to Idexx Laboratories in Q3 2022, an estimated $47.9M increase.
  • TimesSquare Capital Management's biggest Q3 2022 reduction was TransUnion, cutting an estimated $56.2M.
  • TimesSquare Capital Management fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2022, selling an estimated $61M.
  • TimesSquare Capital Management's ten largest holdings make up 15% of its $7.19B portfolio in Q3 2022.
  • TimesSquare Capital Management opened 14 new positions and closed 14 in Q3 2022.
  • TimesSquare Capital Management's portfolio value rose 0.26% quarter-over-quarter to $7.19B.

Based on TimesSquare Capital Management's 13F filing for Q3 2022, filed 9 Nov 2022.